Your search returned 174 studies. (Get alerts for new studies):
- Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-
Conditions: Squamous Cell Lung Cancer
Location: Concord, California
- Dose Ranging Study of a Drug for the Treatment of Acute Migraine
Conditions: Migraine - Acute
Location: Chicago, Illinois
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Oklahoma City, Oklahoma
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Oklahoma City, Oklahoma
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Visual Field Assessment With Subjects Who Receive Either Lyrica Or Sugar Pills
Conditions: Epilepsies, Partial
Location: Edmond, Oklahoma
- Visual Field Assessment With Subjects Who Receive Either Lyrica Or Sugar Pills
Conditions: Epilepsies, Partial
Location: Oklahoma City, Oklahoma
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: Oklahoma City, Oklahoma
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: Oklahoma City, Oklahoma
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid
Location: Oklahoma City, Oklahoma
- Assessment and Tracking of Long-term Alefacept Safety
Conditions: Psoriasis
Location: Oklahoma City, Oklahoma
- A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Conditions: Influenza
Location: Oklahoma City, Oklahoma
- Evaluating the Effectiveness of the LifeVest Defibrillator and Improving Methods for Determining the Use of Implantable Cardioverter Defibrillators
Conditions: Death, Sudden, Cardiac - Myocardial Infarction - Arrhythmias, Cardiac
Location: Oklahoma City, Oklahoma
- Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
Conditions: Alzheimer Disease
Location: Oklahoma City, Oklahoma
- Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
Conditions: Alzheimer Disease
Location: Oklahoma City, Oklahoma
- ChemoFx® PRO - A Post-Market Data Collection Study
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer - Uterine Neoplasms - Endometrial Cancer - Vaginal Cancer - Vulvar Cancer - Cervical Cancer - Lung Cancer - Carcinoid Tumor of Lung - Sarcoma of Lung - Mesothelioma - Colorectal Cancer
Location: Oklahoma City, Oklahoma
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Stage IIA, Stage IIIA, or Stage IIIB Rectal Cancer
Conditions: Colorectal Cancer
Location: Oklahoma City, Oklahoma
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Conditions: Schizophrenia
Location: Oklahoma City, Oklahoma
- A Study of Pemetrexed, Carboplatin and Bevacizumab in Patients With Nonsquamous Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
Location: Oklahoma City, Oklahoma
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus
Location: Oklahoma City, Oklahoma
- A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Conditions: Asthma
Location: Oklahoma City, Oklahoma
- Evaluation of the Cardioblate Closure Device in Facilitating Occlusion of the Left Atrial Appendage
Conditions: Left Atrial Appendage Occlusion
Location: Oklahoma City, Oklahoma
- Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
Conditions: Benign Prostatic Hyperplasia
Location: Bethany, Oklahoma
- Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Conditions: Asthma
Location: Oklahoma City, Oklahoma
- Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Conditions: Asthma
Location: Oklahoma City, Oklahoma
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Oklahoma City, Oklahoma
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Oklahoma City, Oklahoma
- OsseoFix™ Spinal Fracture Reduction System in Treating Spinal Compression Fracture
Conditions: Vertebral Compression Fractures
Location: Edmond, Oklahoma
- Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures
Conditions: Partial Epilepsy
Location: Oklahoma City, Oklahoma
- Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
Conditions: HER2/Neu Over-expressing Locally Advanced Breast Cancer - Metastatic Breast Cancer
Location: Oklahoma City, Oklahoma
- Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease
Conditions: Chronic Kidney Disease - Bacterial Infection
Location: Oklahoma City, Oklahoma
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
Location: Oklahoma City, Oklahoma
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
Location: Oklahoma City, Oklahoma
- Safety and Efficacy of Cariprazine for Mania
Conditions: Bipolar Disorder - Mania
Location: Oklahoma City, Oklahoma
- A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Conditions: Ovarian Cancer - Non Small Cell Lung Cancer - Prostate Cancer - Colorectal Cancer - Gastric Cancer - Esophageal Cancer - Cancer of Head and Neck
Location: Oklahoma City, Oklahoma
- A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastat
Conditions: Castrate-Resistant Prostate Cancer - Hormone Refractory Prostate Cancer
Location: Oklahoma City, Oklahoma
- Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy
Conditions: Advanced Heart Failure
Location: Oklahoma City, Oklahoma
- An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lym
Conditions: Neoplasms Malignant
Location: Oklahoma City, Oklahoma
- Continued Safety Monitoring of Solanezumab in Alzheimer's Disease
Conditions: Alzheimer's Disease
Location: Oklahoma City, Oklahoma
- A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Conditions: Hepatorenal Syndrome Type 1
Location: Oklahoma City, Oklahoma
- Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant Recipients
Conditions: Liver Transplant Recipient
Location: Oklahoma City, Oklahoma
- Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Relapsed Mantle Cell Lymphoma
Conditions: Non-Hodgkin's Lymphoma (NHL)
Location: Oklahoma City, Oklahoma
- Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Relapsed Mantle Cell Lymphoma
Conditions: Non-Hodgkin's Lymphoma (NHL)
Location: Oklahoma City, Oklahoma
- MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis
Conditions: Cystic Fibrosis
Location: Oklahoma City, Oklahoma
- Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM1)
Conditions: Schizophrenia, Paranoid - Schizophrenia, Disorganized - Schizophrenia, Undifferentiated
Location: Oklahoma City, Oklahoma
- Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM1)
Conditions: Schizophrenia, Paranoid - Schizophrenia, Disorganized - Schizophrenia, Undifferentiated
Location: Oklahoma City, Oklahoma
- Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897 AM1)
Conditions: Schizophrenia, Paranoid - Schizophrenia, Disorganized - Schizophrenia, Undifferentiated
Location: Oklahoma City, Oklahoma
- Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897 AM1)
Conditions: Schizophrenia, Paranoid - Schizophrenia, Disorganized - Schizophrenia, Undifferentiated
Location: Oklahoma City, Oklahoma
- Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requi
Conditions: Pain
Location: Oklahoma City, Oklahoma
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional A
Conditions: Type 2 Diabetes
Location: Oklahoma City, Oklahoma
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional A
Conditions: Type 2 Diabetes
Location: Yukon, Oklahoma
- Study of Hypo-fractionated Proton Radiation for Prostate Cancer
Conditions: Prostate Cancer
Location: Oklahoma City, Oklahoma
- Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Conditions: Asthma
Location: Oklahoma City, Oklahoma
- Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Conditions: Asthma
Location: Oklahoma City, Oklahoma
- Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Pati
Conditions: Pain
Location: Oklahoma City, Oklahoma
- Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM2)
Conditions: Bipolar Disorder, Pediatric
Location: Oklahoma City, Oklahoma
- Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM2)
Conditions: Bipolar Disorder, Pediatric
Location: Oklahoma City, Oklahoma
- Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM2)
Conditions: Bipolar Disorder, Pediatric
Location: Oklahoma City, Oklahoma
- Registry Study for Proton Therapy Outcomes
Conditions: Solid Tumors
Location: Oklahoma City, Oklahoma
- Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (A
Conditions: Attention Deficit/Hyperactivity Disorder
Location: Oklahoma City, Oklahoma
- Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients
Conditions: Cystic Fibrosis
Location: Oklahoma City, Oklahoma
- Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia
Conditions: Post Herpetic Neuralgia
Location: Oklahoma City, Oklahoma
- Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia
Conditions: Post Herpetic Neuralgia
Location: Oklahoma City, Oklahoma
- Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
Conditions: Epilepsy
Location: Oklahoma City, Oklahoma
- Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Conditions: Autism Spectrum Disorders
Location: Oklahoma City, Oklahoma
- Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Conditions: Opioid-induced Bowel Dysfunction
Location: Oklahoma City, Oklahoma
- A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
Conditions: Overactive Bladder
Location: Edmond, Oklahoma
- A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
Conditions: Overactive Bladder
Location: Oklahoma City, Oklahoma
- Smoking Cessation Study In Healthy Adolescent Smokers
Conditions: Smoking Cessation
Location: Oklahoma City, Oklahoma
- The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves
Conditions: Symptomatic Severe Aortic Stenosis
Location: Oklahoma City, Oklahoma
- A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded
Conditions: Major Depressive Disorder
Location: Oklahoma City, Oklahoma
- A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction (Non-STEMI) Undergoing Percutaneous Coronary Intervention
Conditions: Myocardial Infarction
Location: Oklahoma City, Oklahoma
- A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
Conditions: Cardiovascular Disease, Rheumatoid Arthritis
Location: Oklahoma City, Oklahoma
- Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Conditions: Bipolar I Disorder
Location: Oklahoma City, Oklahoma
- A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving
Conditions: Rheumatoid Arthritis
Location: Oklahoma City, Oklahoma
- Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001
Conditions: Pain
Location: Oklahoma City, Oklahoma
- A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Conditions: Major Depressive Disorder
Location: Oklahoma City, Oklahoma
- Study of Bevacizumab/mFOLFOX6 Versus Bevacizumab/Folfiri With Biomarker Stratification in Patients With Previously Untreated Metastatic Colorectal Can
Conditions: Colorectal Cancer
Location: Oklahoma City, Oklahoma
- ALK37-005: A Study of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)
Conditions: Opioid-induced Constipation
Location: Oklahoma City, Oklahoma
- A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
Conditions: Celiac Disease
Location: Oklahoma City, Oklahoma
- Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain
Conditions: Chronic Nonmalignant and Nonneuropathic Pain
Location: Oklahoma City, Oklahoma
- Major Depressive Disorder With Mixed Features - Extension
Conditions: Major Depressive Disorder
Location: Oklahoma City, Oklahoma
- A Biomarker Study of Secukinumab in Rheumatoid Arthritis Patients
Conditions: Rheumatoid Arthritis
Location: Oklahoma City, Oklahoma
- Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Conditions: Non-24-Hour Sleep-Wake Disorder
Location: Oklahoma city, Oklahoma
- Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole
Conditions: Schizophrenia
Location: Oklahoma City, Oklahoma
- Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)
Conditions: Major Depressive Disorder
Location: Oklahoma City, Oklahoma
- Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder
Conditions: Major Depressive Disorder
Location: Oklahoma City, Oklahoma
- Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism
Conditions: Male Hypogonadism
Location: Oklahoma City, Oklahoma
- An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C
Conditions: Hepatitis C, Chronic
Location: Oklahoma City, Oklahoma
- Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Conditions: Painful Diabetic Peripheral Neuropathy
Location: Oklahoma City, Oklahoma
- Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Conditions: Painful Diabetic Peripheral Neuropathy
Location: Oklahoma City, Oklahoma
- AMG 151 Amgen Protocol Number 20100761
Conditions: Diabetes Mellitus
Location: Oklahoma City, Oklahoma
- Feeding Trial in Pediatric Patients
Conditions: Developmental Disabilities
Location: Bethany, Oklahoma
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Oklahoma City, Oklahoma
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Oklahoma City, Oklahoma
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer
Conditions: Tumor - Ovarian Cancer
Location: Oklahoma City, Oklahoma
- Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
Conditions: Metastatic Pancreatic Cancer
Location: Oklahoma City, Oklahoma
- Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
Conditions: Autism
Location: Oklahoma City, Oklahoma
- Eslicarbazepine Acetate Monotherapy Long Term Study
Conditions: Epilepsy
Location: Oklahoma City, Oklahoma
- Lisinopril or Carvedilol Phosphate in Reducing Side Effects in Women With HER2-Positive Breast Cancer Receiving Trastuzumab
Conditions: Breast Cancer - Cardiac Toxicity
Location: Oklahoma City, Oklahoma
- Lisinopril or Carvedilol Phosphate in Reducing Side Effects in Women With HER2-Positive Breast Cancer Receiving Trastuzumab
Conditions: Breast Cancer - Cardiac Toxicity
Location: Oklahoma City, Oklahoma
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Oklahoma City, Oklahoma
- Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing E
Conditions: Acute Coronary Syndrome
Location: Oklahoma City, Oklahoma
- Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing E
Conditions: Acute Coronary Syndrome
Location: Oklahoma City, Oklahoma
- Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Conditions: Diarrhea Predominant Irritable Bowel Syndrome
Location: Oklahoma City, Oklahoma
- Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Conditions: Diarrhea Predominant Irritable Bowel Syndrome
Location: Oklahoma City, Oklahoma
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode
Conditions: Adolescent Schizophrenia - Child or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Location: Oklahoma City, Oklahoma
- The Kiva® System as a Vertebral Augmentation Treatment
Conditions: Spinal Fractures - Fractures, Compression - Back Injuries
Location: Edmond, Oklahoma
- Proton Radiotherapy for Recurrent Tumors
Conditions: Tumors
Location: Oklahoma City, Oklahoma
- VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome
Conditions: Acute Coronary Syndrome
Location: Oklahoma City, Oklahoma
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme I
Conditions: Type 2 Diabetes
Location: Oklahoma City, Oklahoma
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme I
Conditions: Type 2 Diabetes
Location: Oklahoma City, Oklahoma
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme I
Conditions: Type 2 Diabetes
Location: Oklahoma City, Oklahoma
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme I
Conditions: Type 2 Diabetes
Location: Yukon, Oklahoma
- Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder
Conditions: Non-24-Hour Sleep-Wake Disorder
Location: Oklahoma city, Oklahoma
- Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Participants With Parkinson's Disease
Conditions: Orthostatic Hypotension - Parkinson's Disease
Location: Oklahoma City, Oklahoma
- A Study of LY2127399 in Patients With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus - Connective Tissue Disease - Autoimmune Disease
Location: Edmond, Oklahoma
- Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Conditions: Kidney Cancer
Location: Oklahoma City, Oklahoma
- Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Conditions: Kidney Cancer
Location: Oklahoma City, Oklahoma
- Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder
Conditions: Major Depressive Disorder
Location: Oklahoma City, Oklahoma
- Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Sub
Conditions: Bladder Neoplasm - Intravesical Drug Administration - Neoplasm Recurrence, Local - Transitional Cell, Carcinoma - Carcinoma in Situ - Mycobacterium
Location: Bethany, Oklahoma
- Vitamin D and Breast Cancer Biomarkers in Female Patients
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Conditions: Hyponatremia - Dilutional Hyponatremia - Inappropriate ADH Syndrome
Location: Oklahoma City, Oklahoma
- OPT - Phase IV Long Term Maintenance Study of Aripiprazole for the Treatment of Irritability Associated With Autistic Disorder
Conditions: Autistic Disorder
Location: Oklahoma City, Oklahoma
- Once-A-Day Pregabalin For Partial Seizures
Conditions: Partial Seizures - Epilepsies, Partial
Location: Oklahoma, Oklahoma
- Once-A-Day Pregabalin For Partial Seizures
Conditions: Partial Seizures - Epilepsies, Partial
Location: Oklahoma City, Oklahoma
- Once-A-Day Pregabalin For Partial Seizures
Conditions: Partial Seizures - Epilepsies, Partial
Location: Oklahoma City, Oklahoma
- Once-A-Day Pregabalin For Partial Seizures
Conditions: Partial Seizures - Epilepsies, Partial
Location: Oklahoma City, Oklahoma
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Melanoma (Skin)
Location: Oklahoma City, Oklahoma
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Melanoma (Skin)
Location: Oklahoma City, Oklahoma
- Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hosp
Conditions: Heart Failure
Location: Oklahoma City, Oklahoma
- Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Conditions: Asthma
Location: Oklahoma City, Oklahoma
- Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Conditions: Primary Fibromyalgia Syndrome
Location: Oklahoma City, Oklahoma
- Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Conditions: Primary Fibromyalgia Syndrome
Location: Oklahoma City, Oklahoma
- Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Conditions: Primary Fibromyalgia Syndrome
Location: Oklahoma City, Oklahoma
- Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Conditions: Primary Fibromyalgia Syndrome
Location: Oklahoma City, Oklahoma
- Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Conditions: Primary Fibromyalgia Syndrome
Location: Oklahoma City, Oklahoma
- Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM2)
Conditions: Bipolar Disorder
Location: Oklahoma City, Oklahoma
- Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM2)
Conditions: Bipolar Disorder
Location: Oklahoma City, Oklahoma
- Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM2)
Conditions: Bipolar Disorder
Location: Oklahoma City, Oklahoma
- Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe
Conditions: Low Back Pain
Location: Oklahoma City, Oklahoma
- Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients
Conditions: Proteinuria - Idiopathic Membranous Nephropathy
Location: Oklahoma City, Oklahoma
- Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Conditions: Tourette's Disorder
Location: Oklahoma City, Oklahoma
- The OMEGA Clinical Trial
Conditions: Atherosclerosis - Coronary Artery Disease
Location: Oklahoma City, Oklahoma
- ION US Post-Approval Study
Conditions: Atherosclerosis - Coronary Artery Disease
Location: Oklahoma City, Oklahoma
- The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Conditions: Chronic Idiopathic Constipation
Location: Oklahoma City, Oklahoma
- Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
Conditions: Non-24-Hour Sleep-Wake Disorder
Location: Oklahoma city, Oklahoma
- Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Conditions: Major Depressive Disorder
Location: Oklahoma City, Oklahoma
- Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Conditions: Major Depressive Disorder
Location: Oklahoma City, Oklahoma
- Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinu
Conditions: Small Cell Lung Carcinoma
Location: Oklahoma City, Oklahoma
- A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Conditions: Perennial Allergic Rhinitis - PAR
Location: Oklahoma City, Oklahoma
- Safety and Efficacy of Vilazodone in Major Depressive Disorder
Conditions: Major Depressive Disorder
Location: Oklahoma City, Oklahoma
- Safety and Efficacy of Vilazodone in Major Depressive Disorder
Conditions: Major Depressive Disorder
Location: Oklahoma City, Oklahoma
- Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN)
Conditions: Diabetic Peripheral Neuropathy
Location: Oklahoma City, Oklahoma
- Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN)
Conditions: Diabetic Peripheral Neuropathy
Location: Oklahoma City, Oklahoma
- The Effect of Vitamin D Supplementation on Muscle Power in Elite Cyclist
Conditions: Muscle Power
Location: Stillwater, Oklahoma
- Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
Conditions: Pulmonary Infections - Pseudomonas Aeruginosa in Cystic Fibrosis
Location: Oklahoma City, Oklahoma
|